Viewing nowCabalin Capsule 75 mg (Pregabalin)
Pregabalin 75mg
Hard capsule · Prescription medication
HK inno.N Co., Ltd.

MFDS item code 201502554 · Approved 2015.04.28 · Insurance code 640007160
Treatment of neuropathic pain and fibromyalgia; adjunctive treatment of partial-onset seizures
This medication is used to treat peripheral and central neuropathic pain in adults and is also used adjunctively to manage partial seizures in epilepsy. It is effective in alleviating symptoms of fibromyalgia. These benefits help improve pain and seizures.
This medicine is administered orally as pregabalin, with the total daily dose divided into 2 doses, regardless of food. Since this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function. (See section ‘5. Patients with renal impairment’.) 1. Neuropathic pain 1) Peripheral neuropathic pain Adults: The initial dose may be 150 mg/day. Depending on the individual patient's response and tolerability, the dose may be increased to 300 mg/day after 3 to 7 days. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 2) Central neuropathic pain Adults: The initial dose may be 150 mg/day. Depending on the individual patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. After an additional week, it may be increased to the target dose of 600 mg/day. If the target daily dose is not tolerated, dose reduction may be considered. (See section ‘4. Discontinuation’.) 2. Epilepsy Adults: The initial dose may be 150 mg/day. Depending on the individual patient's response and tolerability, the dose may be increased to 300 mg/day after 1 week. If necessary, it may subsequently be increased at 7-day intervals to a maximum of 600 mg/day. 3. Fibromyalgia The recommended dose of this medicine for fibromyalgia is 300 mg ~ 450 mg/day. The initial dose is 75 mg twice daily (150 mg/day); based on efficacy and tolerability, it may be increased within 1 week to 150 mg twice daily (300 mg/day). For patients who do not experience sufficient benefit at 300 mg/day, the dose may be increased within 1 week to 225 mg twice daily (450 mg/day). Clinical studies have also been conducted at a dose of 600 mg/day, but there is no evidence of additional benefit or adequate tolerability at this dose. In view of dose-dependent adverse reactions, doses exceeding 450 mg/day are not recommended. 4. Discontinuation Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually over at least 1 week. 5. Patients with renal impairment After entering the systemic circulation, this medicine is primarily excreted by the kidneys as unchanged drug. Since its clearance is directly affected by creatinine clearance, dose reduction in patients with impaired renal function should be individualized based on creatinine clearance. Creatinine clearance [Table 1] is determined using the following formula. *: For women, multiply the result calculated using the above formula by 0.85. This medicine is effectively removed from plasma by hemodialysis (approximately 50% within 4 hours). In patients undergoing hemodialysis, the daily dose of pregabalin should be adjusted based on renal function. In addition to the daily dose based on renal function, an immediately administered supplemental dose should be given after each 4-hour hemodialysis session. [Table 1]. Pregabalin dosing based on renal function Creatinine clearance (CLcr), (mL/min) | Total daily dose of pregabalin a Starting dose (mg/day) Maximum dose (mg/day) | Dosing regimen ≥60 | 150 | 600 | BID or TID ≥30 -<60 | 75 | 300 | BID or TID ≥15 -<30 | 25-50 | 150 | QD or BID <15 | 25 | 75 | QD Supplemental dose after hemodialysis | 25 | 100 | Single dose b TID = total daily dose divided into 3 doses BID = total daily dose divided into 2 doses QD = once daily a: The total daily dose (mg/day) should be divided as specified under the dosing regimen. b: The supplemental dose refers to a dose administered once in addition to the regular dose. 6. Patients with hepatic impairment No dose adjustment is required in patients with hepatic impairment. 8. Elderly patients (65 years and older) Dose reduction may be necessary in elderly patients with impaired renal function.
Children under 12 years of age: Administration is not recommended because there are insufficient data on safety and efficacy. Adolescent patients aged 12 ~17 years: Administration is not recommended because there are insufficient data on safety and efficacy.
This medication may increase the risk of suicidal thoughts or behaviors, so if any mood or behavioral changes occur during treatment, consult a physician immediately. This medication should not be taken if there is hypersensitivity or certain genetic disorders such as lactose intolerance. Patients with diabetes should exercise caution as weight gain may require adjustments in the dosage of blood sugar control medications. If symptoms of angioedema, such as swelling of the face or around the mouth, occur, discontinue use immediately and consult a healthcare professional. Elderly patients should be careful as this medication can cause dizziness or drowsiness, leading to a risk of falls or injury. Transient visual blurring or changes in vision may occur; if these symptoms appear, inform a physician. Sudden discontinuation of this medication may lead to withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so dosage should be gradually reduced according to a physician's instructions. Patients with a history of substance abuse should use this medication with caution, as there may be a risk of misuse, and monitoring for symptoms of misuse or dependence is necessary. Patients with impaired kidney function may require dosage adjustments. Patients with severe heart disease should use this medication with caution. Caution is required when taken with opioid analgesics, as it may increase the risk of central nervous system depression. Patients with respiratory or neurological diseases or elderly patients may be at risk of severe respiratory depression, so dosing should be adjusted. During early pregnancy, there may be a risk of fetal malformations, so it is advisable not to use this medication during pregnancy, and effective contraception should be practiced in women of childbearing potential. Women who are breastfeeding should discuss with their physician the potential transfer of this medication into breast milk, which may require discontinuation of breastfeeding or the medication. This medication may cause dizziness and drowsiness, so changes in symptoms should be monitored before driving or operating dangerous machinery. Rarely, serious skin reactions may occur, so if any skin abnormalities appear, discontinue use immediately and inform a healthcare professional. In case of overdose, symptoms such as confusion, drowsiness, and depression may occur, and immediate emergency treatment is needed. Keep this medication out of reach of children and ensure it is not transferred to other containers.
Suicidal impulse, suicidal behavior, depression, abnormal changes in mood and behavior, angioedema, facial swelling, periorbital swelling, upper respiratory edema, dizziness, drowsiness, loss of consciousness, confusion, mental disorders, blurred vision, changes in vision, insomnia, headache, nausea, anxiety, diarrhea, influenza-like symptoms, restlessness, depression, suicidal thoughts, pain, seizures, sweating, misuse, abuse, dependence, increased serum creatinine, decreased white blood cell count, rhinitis, neutropenia, increased appetite, loss of appetite, hypoglycemia, confusion, spatial disorientation, irritability, depression, relief, decreased libido, insomnia, depersonalization, hypersexuality, restlessness, anxiety, mood swings, emotional lability, emotional elevation, difficulty finding appropriate terminology, hallucinations, abnormal dreams, increased libido, panic attack, inability to inhibit, flat affect, dizziness, drowsiness, ataxia, abnormal motor coordination, balance disorder, amnesia, attention disorder, memory impairment, tremors, dysarthria, sensory disturbances, sensory loss, sedation, hypersomnolence, cognitive impairment, nystagmus, speech disorder, paroxysmal muscle contractions, reflex reduction, motor abnormalities, psychomotor agitation, position-related dizziness, hypersensitivity, burning sensation, activity tremor, syncope, confusion, psychomotor retardation, olfactory disturbances, loss of taste, writing difficulties, blurred vision, diplopia, indirect visual loss, visual disturbances, visual field loss, photophobia, dry eyes, ocular swelling, decreased visual acuity, eye pain, eye fatigue, increased tear secretion, ocular irritation, mydriasis, during vibration, changes in depth perception of vision, strabismus, brightness of vision, dizziness, auditory hypersensitivity, first-degree atrioventricular block, tachycardia, bradycardia, ectopic heartbeat, hypotension, hypertension, flushing, facial flushing, peripheral coldness, dyspnea, epistaxis, cough, nasal congestion, rhinitis, snoring, throat tension, nasal dryness, respiratory depression, vomiting, abdominal distension, constipation, dry mouth, bloating, excessive salivation, gastroesophageal reflux disease, oral sensory loss, ascites, dysphagia, pancreatitis, sweating, papular rash, urticaria, cold sweat, muscle cramps, arthralgia, back pain, limb pain, cervical spasms, joint swelling, myalgia, muscle spasm, neck pain, muscle rigidity, rhabdomyolysis, urination disorders, urinary incontinence, reduced urination, renal failure, erectile dysfunction, delayed ejaculation, sexual dysfunction, dysmenorrhea, amenorrhea, breast pain, nipple discharge, breast enlargement, peripheral edema, edema, gait abnormalities, falls, feeling intoxicated, altered sensation, fatigue, chest tightness, generalized edema, pain, fever, chills, weakness, thirst, weight gain, increased alanine aminotransferase, increased serum creatine phosphokinase, increased aspartate aminotransferase, elevated blood sugar, decreased platelet count, decreased serum potassium, increased serum creatinine, decreased white blood cell count, hypersensitivity, allergic reactions, headache, keratitis, congestive heart failure, pulmonary edema, nausea, diarrhea, tongue swelling, itching, Stevens-Johnson syndrome, toxic epidermal necrolysis, urinary retention, gynecomastia, lethargy, delirium, paralysis (facial paralysis), affective disorder, drowsiness, confused state, depression, agitation, restlessness, seizures
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. Additionally, it is important to store it at a cool temperature between 15 to 30 degrees Celsius to maintain its efficacy.
A hard capsule with a reddish-brown upper part and white lower part containing a white or grayish-white powder.
30 capsules/bottle, 100 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 75mg
Hard capsule · Prescription medication
HK inno.N Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.